8 results
Management of patients with known or suspected malignant pleural effusion (MPE) - An Official ATS/STS/STR Clinical
pleural effusion ... goals of assessing lung ... #Malignant #Pleural ... #Effusions #MPE ... #Algorithm #Management
Dyspnea - Considerations with Malignancy
Directly Malignancy Related:
 - Lymphangitic spread to lung
 - Malignant pleural effusion
Dyspnea - Considerations ... - Malignant pleural ... effusion - Malignant ... Hypercoagulable -> PE ... #algorithm #differential
Management of patients with known or suspected malignant pleural effusion (MPE) - An Official ATS/STS/STR Clinical
pleural effusion ... ATS/STS/STR Clinical ... goals of assessing lung ... #Algorithm #Effusion ... #Malignant #Management
Fibrinous septations in Malignant Pleural Effusion (MPE) - Lung POCUS
 • can be triggered by thoracenteses
Pleural Effusion ... (MPE) - Lung POCUS ... prospective e/o dyspnea ... #Pleural #Effusion ... #MPE #Lung #POCUS
Cryptogenic Organizing Pneumonia (COP)

Cryptogenic Organizing Pneumonia Overview:
 • Idiopathic form of organizing pneumonia
 • formerly BOOP
with CTD, drugs, malignancy ... Unknown • 6-7 cases ... History: cough, dyspnea ... Rare: pleural effusions ... ILD #diagnosis #management
Heart failure with Reduced Ejection Fraction (HFrEF)
Clinical Presentation
1. Typical symptoms: dyspnea, orthopnea paroxysmal noctumal dyspnea, fatigue,
Typical symptoms: dyspnea ... edema, bilateral pleural ... effusions). 1/5 ... pts w/ acute HF ... heartfailure #diagnosis #management
Amiodarone Induced Lung Toxicity Summary

Who?
• 5% of patients
• Dose ≥ 400 mg per day

How?  Possible
and exudative pleural ... effusions • Acute ... Dyspnea 3. ... embolism - Malignancy ... Pulmonary #diagnosis #management
Sjogren's Syndrome Overview

Epidemiology:
• F > M: 9:1
• 5-6th Decades (can be any age)

Autoimmune exocrinopathy multisystemic disease
Hypocomplementemia • Can cause ... Xerotrachea • NSIP: Pleural ... thickening or effusion ... and Arthritis Malignancy ... MALT Lymphoma • Lung